Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurélie Haffner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annales De Pathologie|October 11, 2020
[Point of view: A lesson from lockdown, histopathology through videoconferencing]Clémence Delteil, Aurélie Haffner, Radia Fritih, et al.
Annales De Pathologie|December 6, 2021
[BRAF mutation evolution in melanoma: Myth or reality?]Elicia Molines, Aurélie Haffner, Frédéric Fina, et al.
Radiology Research and Practice|November 9, 2020
Combination of Alcohol and EVOH as a New Embolic Agent: Midterm Tissue and Inflammatory Effects in a Swine ModelJean-François Hak, Farouk Tradi, Mickael Bobot, et al.
Virchows Archiv : an International Journal of Pathology|June 13, 2020
Genetic variant of SRF-rearranged myofibroma with a misleading nuclear expression of STAT6 and STAT6 involvement as 3' fusion partnerHugo Nihous, Nicolas Macagno, Jessica Baud-Massière, et al.
Cardiovascular and Interventional Radiology|October 14, 2024
In Vivo Feasibility of Arterial Embolization with a New Permanent Agar-agar-Based AgentThibault Agripnidis, Alexis Ruimy, Julien Panneau, et al.
The American Journal of Surgical Pathology|March 19, 2021
NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid NeoplasmsNicolas Macagno, Thibault Kervarrec, Pierre Sohier, et al.
Diagnostics (Basel, Switzerland)|October 25, 2024
Comparing Different Methods for the Diagnosis of Liver Steatosis: What Are the Best Diagnostic Tools?Sophie Chopinet, Olivier Lopez, Sophie Brustlein, et al.
Orphanet Journal of Rare Diseases|November 22, 2025
Characterization of a novel SERPINA1 variant carrying two missense mutations: molecular mechanisms and functional impactCeline Leon, Marie-Françoise Odou, Bertrand Roquelaure, et al.
Open Research Europe|August 30, 2023
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor controlMathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annales De Pathologie|October 11, 2020
[Point of view: A lesson from lockdown, histopathology through videoconferencing]Clémence Delteil, Aurélie Haffner, Radia Fritih, et al.
Annales De Pathologie|December 6, 2021
[BRAF mutation evolution in melanoma: Myth or reality?]Elicia Molines, Aurélie Haffner, Frédéric Fina, et al.
Radiology Research and Practice|November 9, 2020
Combination of Alcohol and EVOH as a New Embolic Agent: Midterm Tissue and Inflammatory Effects in a Swine ModelJean-François Hak, Farouk Tradi, Mickael Bobot, et al.
Virchows Archiv : an International Journal of Pathology|June 13, 2020
Genetic variant of SRF-rearranged myofibroma with a misleading nuclear expression of STAT6 and STAT6 involvement as 3' fusion partnerHugo Nihous, Nicolas Macagno, Jessica Baud-Massière, et al.
Cardiovascular and Interventional Radiology|October 14, 2024
In Vivo Feasibility of Arterial Embolization with a New Permanent Agar-agar-Based AgentThibault Agripnidis, Alexis Ruimy, Julien Panneau, et al.
The American Journal of Surgical Pathology|March 19, 2021
NUT Is a Specific Immunohistochemical Marker for the Diagnosis of YAP1-NUTM1-rearranged Cutaneous Poroid NeoplasmsNicolas Macagno, Thibault Kervarrec, Pierre Sohier, et al.
Diagnostics (Basel, Switzerland)|October 25, 2024
Comparing Different Methods for the Diagnosis of Liver Steatosis: What Are the Best Diagnostic Tools?Sophie Chopinet, Olivier Lopez, Sophie Brustlein, et al.
Orphanet Journal of Rare Diseases|November 22, 2025
Characterization of a novel SERPINA1 variant carrying two missense mutations: molecular mechanisms and functional impactCeline Leon, Marie-Françoise Odou, Bertrand Roquelaure, et al.
Open Research Europe|August 30, 2023
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor controlMathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel, et al.
Pageof 1